Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 19

1.

[Organic and functional limitations due to milking phenomenon: a clinical case report].

Gómez-Henry JC, Rodríguez-Pérez FA.

Rev Med Inst Mex Seguro Soc. 2014 May-Jun;52(3):334-6. Spanish.

PMID:
24878096
2.

Trends and projections of hepatitis C virus epidemiology in Latin America.

Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, Dagher L, Gonçales FL, Quiroz JF, Rodriguez-Perez F, Rosado B, Wallace C, Negro F, Silva M.

Liver Int. 2011 Jul;31 Suppl 2:18-29. doi: 10.1111/j.1478-3231.2011.02538.x. Review.

PMID:
21651701
3.

Sustained virologic response among Latino veterans; does it represent the cure of chronic hepatitis C infection?

De Jesús J, Nieves-Santiago P, Rodríguez-Pérez F, Toro DH.

P R Health Sci J. 2010 Dec;29(4):397-401.

PMID:
21261181
4.

[Impact of primary and intravascular catheter-related bacteremia due to coagulase-negative staphylococci in critically ill patients].

Olaechea PM, Alvarez-Lerma F, Palomar M, Insausti J, López-Pueyo MJ, Martínez-Pellús A, Cantón ML; Grupo ENVIN-HELICS.

Med Intensiva. 2011 May;35(4):217-25. doi: 10.1016/j.medin.2010.09.002. Epub 2010 Dec 3. Spanish.

5.

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response.

Buti M, Lurie Y, Zakharova NG, Blokhina NP, Horban A, Teuber G, Sarrazin C, Balciuniene L, Feinman SV, Faruqi R, Pedicone LD, Esteban R; SUCCESS Study Investigators.

Hepatology. 2010 Oct;52(4):1201-7. doi: 10.1002/hep.23816.

PMID:
20683847
6.

Heart rupture predictors in Spanish myocardial infarction patients: evaluation using propensity score analysis.

Ruiz-Bailén M, Expósito-Ruiz M, Castillo-Rivera AM, Rucabado-Aguilar L, Ruiz-García MI, Ramos-Cuadra JA, Ruiz-Valverde A, Gómez-Jiménez J, Benitez-Parejo JL, Cuñat de la Hoz J, Abat FF, Valenzuela JP; ARIAM Group.

Med Sci Monit. 2010 May;16(5):PH49-56.

PMID:
20424560
7.

Sustained ventricular arrhythmias in unstable angina patients: results of the ARIAM database.

Ruiz-Bailén M, Gallego de Guzmán MD, Rucabado-Aguilar L, Expósito-Ruiz M, Aguayo de Hoyos E, Castillo-Rivera AM, Quirós-Barrera R, Galindo-Rodríguez S, Torres-Ruiz JM, Vázquez-García R, Ramos-Cuadra JA, Issa-Khozouz Z; ARIAM Group.

Med Sci Monit. 2009 Jun;15(6):CR280-9.

PMID:
19478698
8.

Sexual activity as a risk factor for hepatitis C in Puerto Rico.

De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Ruiz H, Dueño MI, Alvarez M, Suárez-Pérez E; Gastroenterology Association of Puerto Rico.

Bol Asoc Med P R. 2008 Jul-Sep;100(3):15-20.

PMID:
19227710
9.

Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study.

Zhang L, Qiao Q, Tuomilehto J, Hammar N, Alberti KG, Eliasson M, Heine RJ, Stehouwer CD, Ruotolo G; DECODE Study Group.

Diabetes Res Clin Pract. 2008 Dec;82(3):364-77. doi: 10.1016/j.diabres.2008.08.022. Epub 2008 Oct 14.

PMID:
18922596
10.

Hepatocellular carcinoma: ten years experience among veterans in Puerto Rico.

López-García LJ, Toro DH, Mayol H, Martínez-Souss J, Dueño MI, Rodríguez-Pérez F.

P R Health Sci J. 2007 Jun;26(2):103-7.

PMID:
17722422
11.

Does Silybum marianum play a role in the treatment of chronic hepatitis C?

Torres M, Rodríguez-Serrano F, Rosario DJ, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):69-74.

PMID:
16929590
12.

Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.

PMID:
16929588
13.

Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.

Rodríguez-Pérez F, Suárez-Pérez E, Alvarez-Rohena M, Toro DH.

P R Health Sci J. 2004 Jun;23(2 Suppl):49-56.

PMID:
16929587
14.

Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus.

de Pablos-Velasco PL, Martínez-Martín FJ, Molero R, Rodríguez-Perez F, García-Puente I, Caballero A.

Diabetes Metab. 2005 Nov;31(5):457-62.

15.

Prevalence, awareness, treatment and control of hypertension in a Canarian population. Relationship with glucose tolerance categories. The Guía Study.

de Pablos-Velasco P, Martínez-Martín FJ, Rodríguez Pérez F, Urioste LM, García Robles R.

J Hypertens. 2002 Oct;20(10):1965-71.

PMID:
12359974
16.

Prevalence of obesity in a Canarian community. Association with type 2 diabetes mellitus: the Guía Study.

De Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F.

Eur J Clin Nutr. 2002 Jun;56(6):557-60.

17.

Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population - comparison of the 1997 ADA and the 1985 WHO criteria. The Guía Study.

de Pablos-Velasco PL, Martínez-Martín FJ, Rodríguez-Pérez F, Anía BJ, Losada A, Betancor P; Guia Study.

Diabet Med. 2001 Mar;18(3):235-41.

PMID:
11318846
18.

Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis.

Rodríguez-Pérez F, Isales CM, Groszmann RJ.

Gastroenterology. 1993 Sep;105(3):863-7.

PMID:
7689521
19.

Pharmacologic treatment of portal hypertension.

Rodríguez-Pérez F, Groszmann RJ.

Gastroenterol Clin North Am. 1992 Mar;21(1):15-40. Review.

PMID:
1349005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk